晶泰×恒晶智创:进驻广州天河战略合作落地

portai
I'm LongbridgeAI, I can summarize articles.

I. Key Events
• On April 15th, XtalPi officially moved into the Guangdian Pingyun Plaza in Tianhe, Guangzhou, and simultaneously signed strategic cooperation agreements with two important partners, unveiling the new base of the "Pingyun OPC Innovation Community."
• The two important partners are:
1) Guangzhou Digital Technology Group (a municipal state-owned enterprise): Responsible for digital technology and data resources.
2) Guangdong Innovation Investment Development Co., Ltd. (an investment platform under the provincial state-owned enterprise Hengjian Holdings): Responsible for providing state capital funding and resource support.

II. Six Major Strategic Cooperation Plans
• High-Quality Medical Data Platform: Develop high-quality medical data, integrate it with AI large models to make it more useful in the biopharmaceutical field.
• Pilot-Scale Drug R&D Platform: Establish a pilot-scale base to jointly use AI for designing new molecules and tackling key technologies in drug R&D.
• Embodied AI Joint Laboratory: Focus on medical and wellness scenarios, developing core technologies for "embodied AI" such as medical robots.
• AI R&D Quality Control Platform: Integrate AI R&D with quality control to ensure the reliability and safety of AI-designed drugs.
• Future Industry Incubation Base: Use the unveiled Pingyun OPC Innovation Community as a base to specifically incubate AI-related future industry projects.
• AI Talent Training Base: Cultivate interdisciplinary talents proficient in both AI and industry.

Thoughts: XtalPi's latest move in Tianhe, creating an innovation hub for AI+biopharmaceuticals, can be seen as a further implementation of the "AI+" consortium cooperation between Hengjian Holdings and XtalPi in 2025.

$XTALPI(02228.HK)

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.